The number of reported post-vaccination adverse events and deaths has not changed federal officials’ view on the safety of the two authorized COVID-19 vaccines, the Centers for Disease Control and Prevention (CDC) said Monday. Two hundred and eighty-eight people have died after receiving one of the vaccines, according to reports submitted to the passive Vaccine Adverse…
No Plans to Develop Database for Post-COVID-19 Vaccination Deaths: FDA
Federal health officials have no plans to develop a database for adverse events to people who receive a COVID-19 vaccine, the Food and Drug Administration (FDA) told The Epoch Times. “At this time there are no specific plans to develop a public database of deaths and adverse events associated with vaccination,” a spokesperson said via…
AstraZeneca COVID-19 Vaccine Approved in EU; No Age Restriction Amid Uncertainty of Effectiveness in Older People
The European Medicines Agency (EMA) approved the AstraZeneca COVID-19 vaccine as a preventative measure against the disease on Jan. 29 without any restrictions, despite concerns from German experts who say the vaccine lacks sufficient data on people 65 and older. This is the third COVID vaccine approved by the EMA—the European Union’s drug regulator similar…
No Age Restriction for AstraZeneca COVID-19 Vaccine Amid Uncertainty of Effectiveness in Older People
The European Medicines Agency (EMA) has granted authorization for use of the AstraZeneca COVID-19 vaccine as a preventative measure against the disease on Jan. 29 without any restrictions, despite concerns from German experts who say the vaccine lacks sufficient data on people 65 and older. This is the third COVID vaccine approved by the EMA—the…
WHO Removes Advice Against Moderna Vaccine for Pregnant Women
January 29, 2021
admin
AMERICACCP VirusInternationalModerna vaccinepregnant womenPUBLIC HEALTH INFORMATIONUSUS NewsWorldWorld Health Organization
0 Comment
The World Health Organization removed its advice against administering the Moderna vaccine for the CCP virus on pregnant women, after earlier saying it did not recommend the shot. Earlier, on Tuesday, the WHO said on its website, “While pregnancy puts women at a higher risk of severe COVID-19, the use of this vaccine in pregnant women…
Johnson & Johnson: One-Shot COVID-19 Vaccine 66 Percent Effective in Global Trial
A clinical trial showed that Johnson & Johnson’s COVID-19 vaccine is 66 percent effective at preventing moderate to severe disease, the company said Friday. That level of protection came 28 days after vaccination, according to data from a global phase 3 trial. Onset of protection was observed as early as day 14. The level rose…
Study Finds Significantly More Neurological, Mental Illness Among CCP Virus Survivors
A study by a group at the University of Oxford has found that around one in eight individuals infected by the CCP virus end up suffering from a neurological or psychiatric illnesses within six months. The study, which is yet to be peer-reviewed, also found that for those with a history of neurological or psychiatric illnesses, the…
Novavax Says Vaccine 89.3 Percent Effective in UK Trial, Less in South Africa
Novavax announced that its vaccine against the CCP virus was shown to be 89.3 percent effective in preventing the COVID-19 disease in a trial in the United Kingdom, but less effective in South Africa where a different virus variant is more prevalent. “Strong efficacy in Phase 3 UK trial with over 50 % of cases…
Data Suggests Patients With UK Variant of CCP Virus More Likely to Show Symptoms
Those who tested positive with the UK variant of the CCP virus are more likely to experience symptoms such as coughing than patients with the old variant, data from England suggests. The UK’s Office for Office for National Statistics (ONS) on Wednesday published its latest CCP (Chinese Communist Party) virus infection survey. Participants were asked whether they had experienced…
Moderna Develops New CCP Virus Vaccine for South African Variant
January 26, 2021
admin
AMERICACCP VirusHealth EducationHealth NewsMind & BodyModernaPUBLIC HEALTH INFORMATIONSouth AfricaUSVaccine
0 Comment
Moderna announced on Jan. 25 that it had developed a new CCP virus vaccine to combat a new South African variant of the virus, with plans to advance it into a phase one study. “Out of an abundance of caution and leveraging the flexibility of our mRNA platform, we are advancing an emerging variant booster candidate against…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`